SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines

Translational research hinges on the ability to make observations in model systems and to implement those findings into clinical applications, such as the development of diagnostic tools or targeted therapeutics. Tumor cell lines are commonly used to model carcinogenesis. The same tumor cell line can be simultaneously studied in multiple research laboratories throughout the world, theoretically generating results that are directly comparable. One important assumption in this paradigm is that researchers are working with the same cells. However, recent work using high throughput genomic analyses questions the accuracy of this assumption. Observations by our group and others suggest that experiments reported in the scientific literature may contain pre-analytic errors due to inaccurate identities of the cell lines employed. To address this problem, we developed a simple approach that enables an accurate determination of cell line identity by genotyping 34 single nucleotide polymorphisms (SNPs). Here, we describe the empirical development of a SNP panel identification assay (SPIA) compatible with routine use in the laboratory setting to ensure the identity of tumor cell lines and human tumor samples throughout the course of long term research use.

[1]  C R Cantor,et al.  Chip-based genotyping by mass spectrometry. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Dana Ravid,et al.  A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. , 2007, Cancer letters.

[3]  W. Hahn,et al.  Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. , 2003, Cancer cell.

[4]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[5]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[6]  H. Chaib,et al.  Concordant copy number and transcriptional activity of genes mapping to derivative chromosomes 8 during cellular immortalization in vitro , 2006, Genes, chromosomes & cancer.

[7]  Stefan Schmidt,et al.  Cancer cell line identification by short tandem repeat profiling: power and limitations , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Ward,et al.  Informativeness of genetic markers for inference of ancestry. , 2003, American journal of human genetics.

[9]  S. de Vos,et al.  20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. , 1995, Cancer research.

[10]  D A Scudiero,et al.  The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. , 1997, Anti-cancer drug design.

[11]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[12]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[13]  Russ B Altman,et al.  Genetics. Genomic research and human subject privacy. , 2004, Science.

[14]  K. Pienta,et al.  Genetic characterization of immortalized human prostate epithelial cell cultures. Evidence for structural rearrangements of chromosome 8 and i(8q) chromosome formation in primary tumor-derived cells. , 2000, Cancer genetics and cytogenetics.

[15]  C. Korch,et al.  Widely used prostate carcinoma cell lines share common origins , 2001, The Prostate.

[16]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[17]  M. Waltham,et al.  LCC15-MB Cells are MDA-MB-435: A Review of Misidentified Breast and prostate cell lines , 2004, Clinical & Experimental Metastasis.

[18]  C. Collins,et al.  Evolution of 8p loss in transformed human prostate epithelial cells. , 2004, Cancer genetics and cytogenetics.

[19]  Manfred Kayser,et al.  Proportioning whole-genome single-nucleotide-polymorphism diversity for the identification of geographic population structure and genetic ancestry. , 2006, American journal of human genetics.

[20]  Zhen Lin,et al.  Genomic Research and Human Subject Privacy , 2004, Science.

[21]  R. K. Bright,et al.  Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. , 1997, Cancer research.

[22]  J. Tchinda,et al.  TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.

[23]  Timothy P. L. Smith,et al.  Selection and use of SNP markers for animal identification and paternity analysis in U.S. beef cattle , 2002, Mammalian Genome.

[24]  T. Golub,et al.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.

[25]  C. Meijer,et al.  Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. , 1995, Cancer research.

[26]  M. Kimmel,et al.  Conflict of interest statement. None declared. , 2010 .

[27]  H. Chan,et al.  The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells. , 1997, The Journal of pharmacology and experimental therapeutics.

[28]  K. Kidd,et al.  Developing a SNP panel for forensic identification of individuals. , 2006, Forensic science international.

[29]  Rhitu Chatterjee,et al.  Cases of Mistaken Identity , 2007, Science.

[30]  M. Meyerson,et al.  Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. , 2005, Cancer research.

[31]  T. Ørntoft,et al.  Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPs , 2006, Human mutation.

[32]  J A Thomson,et al.  Short tandem repeat profiling provides an international reference standard for human cell lines , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Drexler,et al.  Widespread intraspecies cross‐contamination of human tumor cell lines arising at source , 1999, International journal of cancer.